References
Buckley C, Oger J, Clover L, et al. (2001) Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 50:73–78
Fauser S, Talazko J, Wagner K, et al. (2005) FDG-PET and MRI in potassium channel antibody-associated non-paraneoplastic limbic encephalitis: correlation with clinical course and neuropsychology. Acta Neurol Scand 111:338–343
Graus F, Delattre JY, Antoine JC, et al. (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135–1140
Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J (2000) Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 123:1481–1494
Shillito P, Molenaar PC, Vincent A, Leys K, Zheng W, van den Berg RJ, et al. (1995) Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol 38:714–722
Vincent A, Buckley C, Schott JM, et al. (2004) Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127:701–712
Voltz R (2002) Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol 1:294–305
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jarius, S., Hoffmann, L.A., Stich, O. et al. Relative frequency of VGKC and ‘classical’ paraneoplastic antibodies in patients with limbic encephalitis. J Neurol 255, 1100–1101 (2008). https://doi.org/10.1007/s00415-008-0845-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-008-0845-3